Your browser doesn't support javascript.
loading
Colorectal cancer statistics, 2020.
Siegel, Rebecca L; Miller, Kimberly D; Goding Sauer, Ann; Fedewa, Stacey A; Butterly, Lynn F; Anderson, Joseph C; Cercek, Andrea; Smith, Robert A; Jemal, Ahmedin.
Afiliación
  • Siegel RL; Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
  • Miller KD; Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
  • Goding Sauer A; Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
  • Fedewa SA; Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
  • Butterly LF; Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
  • Anderson JC; The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
  • Cercek A; The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
  • Smith RA; Department of Veterans Affairs Medical Center, White River Junction, Vermont.
  • Jemal A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
CA Cancer J Clin ; 70(3): 145-164, 2020 05.
Article en En | MEDLINE | ID: mdl-32133645
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Modelos Estadísticos / Programa de VERF Tipo de estudio: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: CA Cancer J Clin Año: 2020 Tipo del documento: Article País de afiliación: Georgia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Modelos Estadísticos / Programa de VERF Tipo de estudio: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: CA Cancer J Clin Año: 2020 Tipo del documento: Article País de afiliación: Georgia